Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
End-of-day quote. End-of-day quote Japan Exchange - 04/16
3704 JPY   -0.30%
04/14CENTOGENE N  : Extends Diagnostics Testing Partnership With Takeda
MT
04/08Japan shares slip on coronavirus concerns
RE
04/07Japan stocks fall on virus woes, but M&As lift some industrials
RE
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Japan shares slip on coronavirus concerns

04/08/2021 | 02:29am EDT

TOKYO, April 8 (Reuters) - Japanese stocks fell on Thursday, weighed by concerns over a spike in domestic coronavirus infections and the potential return of restrictions on economic activity.

The Nikkei 225 Index ended down 0.07% at 29,708.98, while the broader Topix fell 0.79% to 1,951.86.

The governor of Tokyo said on Thursday she would request that the central government adopt emergency measures in the capital in response to a sudden increase in coronavirus infections and the spread of a new variant of the virus.

The western city of Osaka is also set to declare a medical emergency after its number of new infections rose to a record high, which has sparked alarm among public health officials.

Reduced operating hours for restaurants and shops intended to slow the infection rate could hamper economic growth. In addition, more analysts are starting to express concern about Japan's slow pace of vaccination against the coronavirus.

"Japanese equities may slow down relative to other markets," Masayuki Kichikawa, chief macro strategist at Sumitomo Mitsui Asset Management Co said.

"Markets are placing a lot of emphasis on the size of fiscal stimulus and the vaccination rate. More restrictions would be a negative factor because that would delay a recovery in services consumption."

The underperformers on the Topix 30 were Takeda Pharmaceutical Co Ltd, down 3.08%, followed by Mitsubishi UFJ Financial Group Inc, losing 2.51%.

A gainer was Metals Ltd, which rose 4.85%, after the Nikkei newspaper reported that a group led by Bain Capital has emerged as the preferential bidder for a 53% stake in the company worth around $7.3 billion.

Shares of parent company Hitachi Ltd fell 0.87%.

Toshiba Corp fell 0.44% a day after receiving a $20 billion offer from CVC Capital Partners to take it private. Shares hit their highest in more than four years on Wednesday. (Reporting by Stanley White, Editing by Sherry Jacob-Phillips and Amy Caren Daniel)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
HITACHI METALS, LTD. 0.10% 1922 End-of-day quote.22.73%
HITACHI, LTD. 0.98% 5171 End-of-day quote.27.21%
MITSUBISHI UFJ FINANCIAL GROUP, INC. -0.22% 590.3 End-of-day quote.29.42%
NIKKEI 225 0.14% 29683.37 Real-time Quote.8.01%
TAKEDA PHARMACEUTICAL COMPANY LIMITED -0.30% 3704 End-of-day quote.-1.36%
TOSHIBA CORPORATION -6.03% 4600 End-of-day quote.59.45%
All news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
04/14CENTOGENE N  : Extends Diagnostics Testing Partnership With Takeda
MT
04/08Japan shares slip on coronavirus concerns
RE
04/07Japan stocks fall on virus woes, but M&As lift some industrials
RE
04/07TAKEDA PHARMACEUTICAL  : to Host Wave 1 Pipeline Market Opportunity Conference C..
AQ
04/07KAMADA  : Amends GLASSIA License Contract with Takeda
MT
04/06STREET COLOR : Takeda Pharmaceutical Reportedly Suspends Development of Plasma T..
MT
04/05Japanese shares fall on profit booking, checking U.S. rates
RE
04/05SECTOR UPDATE : Health Care Stocks Scratch Out Slim Gains
MT
04/05UPDATE : Molecular Templates Scraps Experimental MT-3724 Drug, Takes Over Takeda..
MT
04/05SECTOR UPDATE : Health Care Stocks Advancing This Afternoon
MT
More news
Financials
Sales 2021 3 217 B 29 561 M 29 561 M
Net income 2021 262 B 2 410 M 2 410 M
Net Debt 2021 4 096 B 37 642 M 37 642 M
P/E ratio 2021 25,3x
Yield 2021 4,86%
Capitalization 5 795 B 53 250 M 53 257 M
EV / Sales 2021 3,07x
EV / Sales 2022 2,89x
Nbr of Employees 47 495
Free-Float 99,0%
Chart TAKEDA PHARMACEUTICAL COMPANY LIMITED
Duration : Period :
Takeda Pharmaceutical Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TAKEDA PHARMACEUTICAL COMPANY LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Average target price 5 197,86 JPY
Last Close Price 3 704,00 JPY
Spread / Highest target 86,3%
Spread / Average Target 40,3%
Spread / Lowest Target 10,7%
EPS Revisions
Managers and Directors
NameTitle
Christophe Weber President, CEO & Representative Director
Constantine Saroukos Chief Financial Officer & Director
Andrew S. Plump Director, Research & Development President
Michael E. Mendelsohn Chief Medical & Scientific Officer
Mwana Lugogo Chief Ethics & Compliance Officer
Sector and Competitors
1st jan.Capitalization (M$)
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.36%53 250
JOHNSON & JOHNSON3.09%422 260
ROCHE HOLDING AG0.16%289 178
PFIZER INC.2.15%209 739
NOVARTIS AG-3.73%197 072
MERCK & CO., INC.-5.29%194 049